These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 33371687)
1. Self-Assembling Derivative of Hydrocortisone as Glucocorticoid Receptor-Targeted Nanotherapeutics for Synergistic, Combination Therapy against Colorectal Tumor. Sridharan K; Rathore B; Yousuf M; Reddy Rachamalla HK; Jinka S; Jaggarapu MMCS; Banerjee R Mol Pharm; 2021 Mar; 18(3):1208-1228. PubMed ID: 33371687 [TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid receptor-targeted liposomal delivery system for delivering small molecule ESC8 and anti-miR-Hsp90 gene construct to combat colon cancer. Jinka S; Rachamalla HK; Bhattacharyya T; Sridharan K; Sekhar Jaggarapu MMC; Yakati V; Banerjee R Biomed Mater; 2021 Feb; 16(2):024105. PubMed ID: 33434900 [TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid receptor mediated sensitization of colon cancer to photodynamic therapy induced cell death. Chilakamarthi U; Mahadik NS; Bhattacharyya T; Gangadhar PS; Giribabu L; Banerjee R J Photochem Photobiol B; 2024 Feb; 251():112846. PubMed ID: 38237432 [TBL] [Abstract][Full Text] [Related]
4. Synergistic anti-tumor effects of Liraglutide, a glucagon-like peptide-1 receptor agonist, along with Docetaxel on LNCaP prostate cancer cell line. Eftekhari S; Montazeri H; Tarighi P Eur J Pharmacol; 2020 Jul; 878():173102. PubMed ID: 32283060 [TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid receptor-mediated delivery of nano gold-withaferin conjugates for reversal of epithelial-to-mesenchymal transition and tumor regression. Agarwalla P; Mukherjee S; Sreedhar B; Banerjee R Nanomedicine (Lond); 2016 Oct; 11(19):2529-46. PubMed ID: 27622735 [TBL] [Abstract][Full Text] [Related]
6. 15-Deoxy-Delta12,14-prostaglandin J2 enhances docetaxel anti-tumor activity against A549 and H460 non-small-cell lung cancer cell lines and xenograft tumors. Fulzele SV; Chatterjee A; Shaik MS; Jackson T; Ichite N; Singh M Anticancer Drugs; 2007 Jan; 18(1):65-78. PubMed ID: 17159504 [TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid Receptor-Targeted Liposomal Codelivery of Lipophilic Drug and Anti-Hsp90 Gene: Strategy to Induce Drug-Sensitivity, EMT-Reversal, and Reduced Malignancy in Aggressive Tumors. Mondal SK; Jinka S; Pal K; Nelli S; Dutta SK; Wang E; Ahmad A; AlKharfy KM; Mukhopadhyay D; Banerjee R Mol Pharm; 2016 Jul; 13(7):2507-23. PubMed ID: 27184196 [TBL] [Abstract][Full Text] [Related]
8. Role of nonsteroidal anti-inflammatory drug-activated gene-1 in docetaxel-induced cell death of human colorectal cancer cells with different p53 status. Kim IY; Park SY; Kang Y; Thapa D; Choi HG; Kim JA Arch Pharm Res; 2011 Feb; 34(2):323-30. PubMed ID: 21380817 [TBL] [Abstract][Full Text] [Related]
9. Luteinizing hormone-releasing hormone receptor-targeted deslorelin-docetaxel conjugate enhances efficacy of docetaxel in prostate cancer therapy. Sundaram S; Durairaj C; Kadam R; Kompella UB Mol Cancer Ther; 2009 Jun; 8(6):1655-65. PubMed ID: 19509261 [TBL] [Abstract][Full Text] [Related]
10. Trans-scirpusin A showed antitumor effects via autophagy activation and apoptosis induction of colorectal cancer cells. Hong EH; Heo EY; Song JH; Kwon BE; Lee JY; Park Y; Kim J; Chang SY; Chin YW; Jeon SM; Ko HJ Oncotarget; 2017 Jun; 8(25):41401-41411. PubMed ID: 28489607 [TBL] [Abstract][Full Text] [Related]
11. Enhancement of docetaxel anticancer activity by a novel diindolylmethane compound in human non-small cell lung cancer. Ichite N; Chougule MB; Jackson T; Fulzele SV; Safe S; Singh M Clin Cancer Res; 2009 Jan; 15(2):543-52. PubMed ID: 19147759 [TBL] [Abstract][Full Text] [Related]
12. Bis-arylidene oxindoles for colorectal cancer nanotherapy. Bhattacharyya T; Mishra T; Das D; Adhikari SS; Banerjee R Bioorg Chem; 2024 May; 146():107294. PubMed ID: 38507997 [TBL] [Abstract][Full Text] [Related]
13. Co-delivery of Docetaxel and Disulfonate Tetraphenyl Chlorin in One Nanoparticle Produces Strong Synergism between Chemo- and Photodynamic Therapy in Drug-Sensitive and -Resistant Cancer Cells. Gaio E; Conte C; Esposito D; Miotto G; Quaglia F; Moret F; Reddi E Mol Pharm; 2018 Oct; 15(10):4599-4611. PubMed ID: 30148955 [TBL] [Abstract][Full Text] [Related]
14. Multifunctional tumor-targeting nanocarriers based on hyaluronic acid-mediated and pH-sensitive properties for efficient delivery of docetaxel. Song S; Chen F; Qi H; Li F; Xin T; Xu J; Ye T; Sheng N; Yang X; Pan W Pharm Res; 2014 Apr; 31(4):1032-45. PubMed ID: 24154802 [TBL] [Abstract][Full Text] [Related]
15. Piperine and Celecoxib synergistically inhibit colon cancer cell proliferation via modulating Wnt/β-catenin signaling pathway. Srivastava S; Dewangan J; Mishra S; Divakar A; Chaturvedi S; Wahajuddin M; Kumar S; Rath SK Phytomedicine; 2021 Apr; 84():153484. PubMed ID: 33667839 [TBL] [Abstract][Full Text] [Related]
16. Synergistic anti-proliferative effects of gambogic acid with docetaxel in gastrointestinal cancer cell lines. Zou Z; Xie L; Wei J; Yu L; Qian X; Chen J; Wang T; Liu B BMC Complement Altern Med; 2012 Apr; 12():58. PubMed ID: 22546220 [TBL] [Abstract][Full Text] [Related]
17. Insulin enhancement of the antitumor activity of chemotherapeutic agents in colorectal cancer is linked with downregulating PIK3CA and GRB2. Agrawal S; Woźniak M; Łuc M; Makuch S; Pielka E; Agrawal AK; Wietrzyk J; Banach J; Gamian A; Pizon M; Ziółkowski P Sci Rep; 2019 Nov; 9(1):16647. PubMed ID: 31719636 [TBL] [Abstract][Full Text] [Related]
18. Dual drug loaded liposome bearing apigenin and 5-Fluorouracil for synergistic therapeutic efficacy in colorectal cancer. Sen K; Banerjee S; Mandal M Colloids Surf B Biointerfaces; 2019 Aug; 180():9-22. PubMed ID: 31015105 [TBL] [Abstract][Full Text] [Related]
19. Gambogic acid induces apoptosis and inhibits colorectal tumor growth via mitochondrial pathways. Huang GM; Sun Y; Ge X; Wan X; Li CB World J Gastroenterol; 2015 May; 21(20):6194-205. PubMed ID: 26034354 [TBL] [Abstract][Full Text] [Related]
20. Exploring the Promising Potential of High Permeation Vesicle-Mediated Localized Transdermal Delivery of Docetaxel in Breast Cancer To Overcome the Limitations of Systemic Chemotherapy. Bathara M; Date T; Chaudhari D; Ghadi R; Kuche K; Jain S Mol Pharm; 2020 Jul; 17(7):2473-2486. PubMed ID: 32496783 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]